Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways-Reference-Cited by-全球学者库

Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways

Published:2013-10 Issue:3 Volume:205 Page:212-221
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Chun Jaemoo,Kim Yeong Shik

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference38 articles.

1. Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression;Carvalho;Breast Cancer Res.,2005

2. CIP2A is associated with human breast cancer aggressivity;Come;Clin. Cancer Res.,2009

3. Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitive human prostate cancer cells;Hsieh;Int. J. Oncol.,2001

4. Tumour-cell invasion and migration: diversity and escape mechanisms;Friedl;Nat. Rev. Cancer,2003

5. Regulation of matrix metalloproteinase expression in tumor invasion;Westermarck;FASEB J.,1999

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemical and Pharmacological Studies of Natural Saponins from Platycodon grandiflorum;Records of Natural Products;2023-12-17

2. New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story;Journal of Molecular Structure;2023-12

3. Platycodin D induces apoptotic cell death through PI3K/AKT and MAPK/ERK pathways and synergizes with venetoclax in acute myeloid leukemia;European Journal of Pharmacology;2023-10

4. A safety study on ultra‑high or moderate static magnetic fields combined with platycodin D against lung cancer;Oncology Letters;2023-09-04

5. Abrogating Metastatic Properties of Triple-Negative Breast Cancer Cells by EGFR and PI3K Dual Inhibitors;Cancers;2023-08-04